LLNI Funded Publications
We are incredibly proud of every publication that LLNI funding has contributed to.
Publishing and sharing this information and data is integral to finding answers for the future.
Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
Author:Chan KK
Other Authors: Matchett KB, Coulter JA, Yuen HF, McCrudden CM, Zhang SD, Irwin GW, Davidson MA, Rülicke T, Schober S, Hengst L, Jaekel H, Platt-Higgins A, Rudland PS, Mills KI, Maxwell P, El-Tanani M, Lappin TR,
Last Updated:04/08/2019
Source:PubMed
Original Source:PubMed
Type:Journal Article
DOI:10.18632/oncotarget.16368
Journal:Oncotarget
Volume:8
Issue:24
Pages:38251-38263
Date: June 2017
